Fischer David B 4

4 · BALCHEM CORP · Filed Dec 5, 2025

Form 4

Period: 2025-12-03

Director

Transactions

Exercise/Conversion
Common Stock
2025-12-03$74.57/sh+3,383$252,270→ 13,372 total
Exercise/Conversion
Common Stock
2025-12-03$84.09/sh+2,617$220,064→ 15,989 total
Sale
Common Stock
2025-12-03$153.91/sh−6,000$923,458→ 9,989 total
Sale
Common Stock
2025-12-03$154.15/sh−2,000$308,291→ 7,989 total
Exercise/Conversion
Stock Options
2025-12-03−3,383→ 0 total
Exercise: $74.57Exp: 2028-02-15→ Common Stock (3,383 underlying)
Exercise/Conversion
Stock Options
2025-12-03−2,617→ 0 total
Exercise: $84.09Exp: 2029-02-13→ Common Stock (2,617 underlying)

Footnotes (5)

[F1]Exercise of fully vested non-qualified stock options.
[F2]This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
[F3]This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
[F4]Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
[F5]Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.

Documents

1 file